Nadine Jagerovic

Instituto de Química Médica — Spain

Medicine · Health Sciences

36h-index3.6kcitations225works19.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cannabis and Cannabinoid Research(54), X-ray Diffraction in Crystallography(50), Crystallization and Solubility Studies(48), Crystallography and molecular interactions(37), Pharmacological Receptor Mechanisms and Effects(34)

Publications225 total

Investigation in the CB1 and CB2 receptor binding profile and intrinsic activity of (−) and (+)-enantiomers of some naturally occurring phytocannabinoids or synthetic derivatives
European Journal of Medicinal Chemistry Reports·2025· 1 citedOpen Access
Progress on the development of Class A GPCR‐biased ligands
British Journal of Pharmacology·2024· 15 citedOpen Access
Homodimerization of CB2 cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling
Pharmacological Research·2024· 83 citedOpen Access
Homodimerization of CB <sub>2</sub> cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling
2024Open Access
Homodimerization of Cb2 Cannabinoid Receptor Triggered by a Bivalent Ligand Enhances Cellular Signaling
SSRN Electronic Journal·2024Open Access
Administration of Linoleoylethanolamide Reduced Weight Gain, Dyslipidemia, and Inflammation Associated with High-Fat-Diet-Induced Obesity
Nutrients·2023· 18 citedOpen Access
Activation of CB2R by synthetic CB2R agonist, PM289, improves brain endothelial barrier properties, decreases inflammatory response and enhances endothelial repair
NeuroImmune Pharmacology and Therapeutics·2023· 5 citedOpen Access
Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure–Activity Relationship
ACS Medicinal Chemistry Letters·2022· 3 citedOpen Access
Targeting CB2 and TRPV1: Computational Approaches for the Identification of Dual Modulators
Frontiers in Molecular Biosciences·2022· 14 citedOpen Access
The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB2 Receptors
Frontiers in Pharmacology·2022· 8 citedOpen Access
Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis
Molecules·2021· 19 citedOpen Access
Cannabinoid-based Anti-cancer Strategies: Slowly Approaching the Bedside
Frontiers in anti-cancer drug discovery·2021· 2 cited
Palmitoleoylethanolamide Is an Efficient Anti-Obesity Endogenous Compound: Comparison with Oleylethanolamide in Diet-Induced Obesity
Nutrients·2021· 24 citedOpen Access
Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System
International Journal of Molecular Sciences·2021· 44 citedOpen Access
Pain and suffering
2021
Synthetic and Natural Derivatives of Cannabidiol
Advances in experimental medicine and biology·2021· 6 cited
Ligand-based drug design approaches for the identification of novel GPR55 modulators
Proceedings of 6th International Electronic Conference on Medicinal Chemistry·2020Open Access
Exploring the orphan GPCR GPR18 through novel synthetic cannabidiol derivatives
Proceedings of 6th International Electronic Conference on Medicinal Chemistry·2020Open Access
Exploring the thienopyrimidine scaffold for GPR55
2020
Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?
Journal of Medicinal Chemistry·2020· 52 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Paula Morales(19), Pilar Goya(18), José Elguero(17), Laura Hernández‐Folgado(8), Javier Fernández‐Ruíz(6), Fernando Rodrı́guez de Fonseca(6), Hans‐Heinrich Limbach(6), Concepción Foces‐Foces(6), Gemma Navarro(5), Rafael Franco(5), Antonia Serrano(5), Francisco Aguilar‐Parrilla(5), María Gómez‐Cañas(5), Patricia H. Reggio(4), Francisco Javier Pavón(4), Ibón Alkorta(4), Luís F. Callado(4), Rocı́o Girón(4), Oliver Klein(3), Artur M. S. Silva(3)